384 related articles for article (PubMed ID: 25663103)
21. Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients.
Kraal KC; Bleeker GM; van Eck-Smit BL; van Eijkelenburg NK; Berthold F; van Noesel MM; Caron HN; Tytgat GA
Eur J Cancer; 2017 May; 76():188-196. PubMed ID: 28329731
[TBL] [Abstract][Full Text] [Related]
22. Advances in the surgical treatment of neuroblastoma: a review.
Murphy JM; La Quaglia MP
Eur J Pediatr Surg; 2014 Dec; 24(6):450-6. PubMed ID: 25486413
[TBL] [Abstract][Full Text] [Related]
23. How well do image-defined risk factors (IDRFs) predict surgical outcomes and survival in patients with neuroblastoma? A systematic review and meta-analysis.
Parhar D; Joharifard S; Lo AC; Schlosser MP; Daodu OO
Pediatr Surg Int; 2020 Aug; 36(8):897-907. PubMed ID: 32533235
[TBL] [Abstract][Full Text] [Related]
24. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
Strother DR; London WB; Schmidt ML; Brodeur GM; Shimada H; Thorner P; Collins MH; Tagge E; Adkins S; Reynolds CP; Murray K; Lavey RS; Matthay KK; Castleberry R; Maris JM; Cohn SL
J Clin Oncol; 2012 May; 30(15):1842-8. PubMed ID: 22529259
[TBL] [Abstract][Full Text] [Related]
25. Can Image-Defined Risk Factors Predict Surgical Complications in Localized Neuroblastoma?
Yoneda A; Nishikawa M; Uehara S; Oue T; Usui N; Inoue M; Fukuzawa M; Okuyama H
Eur J Pediatr Surg; 2016 Feb; 26(1):117-22. PubMed ID: 26528852
[TBL] [Abstract][Full Text] [Related]
26. Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and image-defined risk factors.
Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Canale S; Sarnacki S
Pediatr Blood Cancer; 2015 Feb; 62(2):257-261. PubMed ID: 25284263
[TBL] [Abstract][Full Text] [Related]
27. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
[TBL] [Abstract][Full Text] [Related]
28. Contraindications and image-defined risk factors in laparoscopic resection of abdominal neuroblastoma.
Tanaka Y; Kawashima H; Mori M; Fujiogi M; Suzuki K; Amano H; Morita K; Arakawa Y; Koh K; Oguma E; Iwanaka T; Uchida H
Pediatr Surg Int; 2016 Sep; 32(9):845-50. PubMed ID: 27461435
[TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma--a surgical perspective.
Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
[TBL] [Abstract][Full Text] [Related]
30. Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries.
Rich BS; McEvoy MP; Kelly NE; Oh E; Abramson SJ; Price AP; Cheung NK; La Quaglia MP
J Pediatr Surg; 2011 Jan; 46(1):103-7. PubMed ID: 21238649
[TBL] [Abstract][Full Text] [Related]
31. Surgical complications in abdominal tumor surgery in children. Experiences at a single oncological center.
Günther P; Tröger J; Holland-Cunz S; Behnisch W; Hinz U; Romero P; Schenk JP
Eur J Pediatr Surg; 2009 Oct; 19(5):297-303. PubMed ID: 19449285
[TBL] [Abstract][Full Text] [Related]
32. Reasonable surgery for thoracic neuroblastoma in infants and children.
Catalano PW; Newton WA; Williams TE; Clatworthy HW; Kilman JW
J Thorac Cardiovasc Surg; 1978 Oct; 76(4):459-64. PubMed ID: 703352
[TBL] [Abstract][Full Text] [Related]
33. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
34. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease.
Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F
Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357
[TBL] [Abstract][Full Text] [Related]
35. Image-defined risk factors in localized thoracic neuroblastoma and ganglioneuroma.
Butzer SK; Krug B; Reisberg M; Fuchs J; Warmann SW; Hubertus J; Körber F; Berthold F; Simon T; Hero B
Pediatr Blood Cancer; 2023 Oct; 70(10):e30605. PubMed ID: 37534915
[TBL] [Abstract][Full Text] [Related]
36. Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study.
Holmes K; Pötschger U; Pearson ADJ; Sarnacki S; Cecchetto G; Gomez-Chacon J; Squire R; Freud E; Bysiek A; Matthyssens LE; Metzelder M; Monclair T; Stenman J; Rygl M; Rasmussen L; Joseph JM; Irtan S; Avanzini S; Godzinski J; Björnland K; Elliott M; Luksch R; Castel V; Ash S; Balwierz W; Laureys G; Ruud E; Papadakis V; Malis J; Owens C; Schroeder H; Beck-Popovic M; Trahair T; Forjaz de Lacerda A; Ambros PF; Gaze MN; McHugh K; Valteau-Couanet D; Ladenstein RL;
J Clin Oncol; 2020 Sep; 38(25):2902-2915. PubMed ID: 32639845
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and outcome of thoracic neuroblastoma.
Häberle B; Hero B; Berthold F; von Schweinitz D
Eur J Pediatr Surg; 2002 Jun; 12(3):145-50. PubMed ID: 12101494
[TBL] [Abstract][Full Text] [Related]
38. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H;
Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919
[TBL] [Abstract][Full Text] [Related]
39. Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma.
Temple WC; Vo KT; Matthay KK; Balliu B; Coleman C; Michlitsch J; Phelps A; Behr S; Zapala MA
Cancer Med; 2021 Apr; 10(7):2232-2241. PubMed ID: 33314708
[TBL] [Abstract][Full Text] [Related]
40. Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee.
Iehara T; Yoneda A; Yokota I; Takahashi H; Teramukai S; Kamijyo T; Nakazawa A; Takimoto T; Kikuta A; Yagyu S; Ikeda H; Nakagawara A; Tajiri T;
Pediatr Blood Cancer; 2019 Nov; 66(11):e27914. PubMed ID: 31342649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
